Perelel: Female OB/GYN-Founded Vitamin Company Secures $6 Million
Summary
This year, Perelel continued to experience rapid growth as the business accelerated to serve more women through key hormonal life stages. Committed to uplifting female leadership talent, Perelel keeps adding to its majority female investor group:This funding round comes at a time of intensified focus on womens health as efforts start to reach new levels, including the first White House Initiative on Womens Health Research. Last year, Perelel reaffirmed its commitment to advocating for increased and improved research in womens health by partnering with The HOPE Project, the largest research initiative to-date led in part by Stanford University School of Medicine to uncover the causes of pregnancy loss; and launched the Hormonal Hotline tapping into Perelels Medical Co-Founder Dr. Banafsheh Bayati to answer questions many want to know but are too embarrassed to ask. We saw in Perelel an opportunity to back a brand offering women high quality, carefully targeted solutions in a space that has traditionally lacked transparency and investment. Since then, the brand has consistently demonstrated its ability to resonate and support women throughout different stages of their reproductive journey, said Rachel Harris, Partner at Unilever Ventures.